Salix Pharmaceuticals (SLXP) and Progenics (PGNX) report "positive" highly statistically...

|About: Salix Pharmaceuticals, Ltd. (SLXP)|By:, SA News Editor

Salix Pharmaceuticals (SLXP) and Progenics (PGNX) report "positive" highly statistically significant results of the Phase 3 of oral methylnaltrexone for the treatment of opioid-induced constipation in subjects with chronic, non-cancer pain. SLXP +11%, PGNX +18.8% premarket. (PR)